Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress? - Wikidata - awgldk - TriplyDB

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

http://www.wikidata.org/entity/Q35667802

about

Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1 Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study.Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: Differences between malignant and benign.Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer Is T790M mutation the key in development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)?Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer.

P2860

Q26781365-D1ECF207-B42D-45E2-9F18-C066C2EEE736 Q28484906-6597B2E7-66B3-4E22-91F4-815CDA7028AE Q28534136-172775A6-5152-4D9B-A605-1FB22615410E Q34704781-C1757827-560E-4955-9A54-82C016E88C03 Q35912759-3B595133-6019-43B2-A66B-6FE3C18F3325 Q36477766-A1BB7C4D-6EB6-48B0-AEB4-2B219D8AF71A Q36776988-C5EBF166-FFE4-4FB5-AF6D-A1C008519349 Q36972377-0DEB52B7-3E60-4C45-A9A5-9854DD71C8AB Q40341970-41A4FEDA-003D-4EBA-9DBC-30DAC31A663A Q47218543-39E5664E-0E30-4EF3-BE35-0E4C7A4ABEC0

P2860

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

http://www.wikidata.org/entity/Q35667802

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

@ast

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

@en

type

label

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

@ast

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

@en

prefLabel

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

@ast

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

@en

P1433

Q35667802-D45FABA8-EF8A-439F-B202-1D63DF5FAA4F

P1476

Q35667802-43DCF0C4-D5C3-45A0-98A1-05371993E1D1

P2093

Q35667802-161865F8-3116-42C5-AAE6-2B5B476F122C

Q35667802-8AED3D97-F229-41A7-B729-110719B94583

Q35667802-FEE98872-D650-465C-A4D0-52B5AA5F560D

P2860

Q35667802-006FA5F9-CE29-4DF4-B7A5-259359C9F7B9

Q35667802-01545DF4-C420-4472-913C-FBA36646D6C8

Q35667802-0AB44685-C4D1-4E6C-8DE1-595BA3FDBF5F

Q35667802-1E315AE2-5EB4-4007-8B9A-FF6E1E27B4EE

Q35667802-28BC86B7-DA2E-487E-A68A-E6E1AF87120B

Q35667802-2C2D09A5-6C30-4D52-A561-BFF72D9940D7

Q35667802-334C1FF8-07CD-4BB9-B1EF-843C11F2FD30

Q35667802-3B305E3A-3154-4C1D-A854-B5878695CDE4

Q35667802-41E15B70-5F70-40C9-8F1C-814E6379C1BA

Q35667802-439A060B-947F-4C11-95BA-52FA570E1690

P304

Q35667802-3C9446BF-C633-4A9B-BAC5-D66E4D2B36FF

P31

Q35667802-FB57F8E5-57CA-463C-BEF6-E7AA883DB3B4

P356

Q35667802-4B7D61B8-AA16-48DF-9EE1-B17FF4225A1C

P433

Q35667802-C1B2C221-2473-4B44-8C05-20C015CAC80E

P478

Q35667802-C83596A7-5BFD-45F5-AB72-6A9C81E5A997

P577

Q35667802-20FA7F36-8A76-4B59-BBF2-41A6BC0B05A7

P5875

Q35667802-E8F9F96D-9A61-4767-A451-B40E7AA90EA2

P698

Q35667802-274A8706-3A65-41EC-AAFF-03A3300CE9CC

P932

Q35667802-D6CD28E5-F170-49AC-8791-15CCC216F80E

P356

J.ISSN.2072-1439.2010.11.11

P1433

Journal of thoracic disease

P1476

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

@en

P2093

Desmond N Carney

http://www.w3.org/2001/XMLSchema#string

Elizabeth Smyth

http://www.w3.org/2001/XMLSchema#string

Grzegorz Korpanty

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

Tumor angiogenesis: therapeutic implications

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

The biology of VEGF and its receptors

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Vascular endothelial growth factor is a secreted angiogenic mitogen

Purification and characterization of hypoxia-inducible factor 1

P304

19-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2072-1439.2010.11.11

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234109914

http://www.w3.org/2001/XMLSchema#string

P698

22263059

http://www.w3.org/2001/XMLSchema#string

P932

3256499

http://www.w3.org/2001/XMLSchema#string